 "Representative Image")
Exactly three years ago on November 5, 2015, Indian drug major Dr Reddy's Laboratories Limited had received a Warning Letter from the US Food and Drug Administration (USFDA) for the poor state of affairs in three of its manufacturing facilities.
The close-out letter from the USFDA continues to elude the company even after three years of remediation in the wake of latest round of concerns raised by the FDA inspectors regarding its Oncology formulations facility at Duvvada in Visakhapatnam.
The Mohali plant of Sun Pharma was the only other recent example that comes close to this situation. The USFDA had
